MiNK Therapeutics (INKT) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.06
-0.87
-0.68
-0.49

Details

Expected EPS
-0.546667
Actual EPS
-1.06
Surprise EPS
-0.51
Surprise Percent
+93.9%

Description

MiNK Therapeutics (INKT) has reported earnings of -1.06 per share for Q3 2025.

0 Comments

Share your thoughts